|
90
|
334
|
4l42A |
Crystal structures of human p70s6k1-pif |
|
92
|
291
|
4l3lA |
Crystal structures of human p70s6k1 kinase domain (zinc anomalous) |
|
81
|
275
|
4kabA |
Focal adhesion kinase catalytic domain in complex with 3-methyl-1,4-dihydro-pyrazolo[4,5-c]pyrazole |
|
76
|
266
|
4l7sA |
Kinase domain mutant of human itk in complex with an aminobenzothiazole inhibitor |
|
83
|
270
|
4k8aA |
Fragment-based discovery of focal adhesion kinase inhibitors |
|
94
|
286
|
4l01A |
Crystal structure of the v658f apo jak1 pseudokinase domain |
|
101
|
329
|
4kwpA |
Crystal structure of human ck2-alpha in complex with a benzimidazole inhibitor (k164) at 1.25 a resolution |
|
87
|
348
|
4kipA |
Crystal structure of mitogen-activated protein kinase 14 (p38-h5) complex with 2-(2-chlorophenyl)-n-(5-(cyclopropylcarbamoyl)-2-methylphenyl)-1,3-thiazole-5-carboxamide |
|
95
|
291
|
4kbkA |
Ck1d in complex with (3s)-3-{4-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]pyridin-2-yl}morpholine inhibitor |
|
111
|
348
|
4l8mA |
Human p38 map kinase in complex with a dibenzoxepinone |
|
88
|
271
|
4k9yA |
Focal adhesion kinase catalytic domain in complex with 1-[4-(6-amino-purin-9-yl)-phenyl]-3-(5-tert-butyl-2-p-tolyl-2h-pyrazol-3-yl)-urea |
|
105
|
356
|
4kkgA |
Crystal structure of apo and amp-bound jnk3 |
|
69
|
277
|
4lghA |
Crystal structure of 1nm-pp1 bound to analog-sensitive src kinase |
|
111
|
367
|
4l7fA |
Co-crystal structure of jnk1 and ax13587 |
|
85
|
298
|
4kd1A |
Cdk2 in complex with dinaciclib |
|
92
|
291
|
4kb8A |
Ck1d in complex with 1-{4-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]pyridin-2-yl}-n-methylmethanamine ligand |
|
81
|
338
|
4l46A |
Crystal structures of human p70s6k1-wt |
|
88
|
337
|
4l44A |
Crystal structures of human p70s6k1-t389a (form ii) |
|
90
|
300
|
4krdA |
Crystal structure of pho85-pcl10 complex |
|
91
|
328
|
4li5A |
Egfr-k in complex with n-[3-[[5-chloro-4-(1h-indol-3-yl)pyrimidin-2-yl]amino]-4-methoxy-phenyl] prop-2-enamide |
|
107
|
356
|
4kkeA |
The crystal structure of amp-bound jnk3 |
|
76
|
290
|
4l67A |
Crystal structure of catalytic domain of pak4 |
|
80
|
274
|
4jx7A |
Crystal structure of pim1 kinase in complex with inhibitor 2-[(trans-4-aminocyclohexyl)amino]-4-{[3-(trifluoromethyl)phenyl]amino}pyrido[4,3-d]pyrimidin-5(6h)-one |
|
85
|
337
|
4l43A |
Crystal structures of human p70s6k1-t389a (form i) |
|
87
|
301
|
4krcA |
Crystal structure of pho85-pcl10-atp-gamma-s complex |
|
114
|
356
|
4kkhA |
The crystal structure of inhibitor-bound jnk3 |
|
81
|
265
|
4kioA |
Kinase domain mutant of human itk in complex with a covalently-binding inhibitor |
|
91
|
307
|
4l53A |
Crystal structure of (1r,4r)-4-{4-[7-amino-2-(1,2,3-benzothiadiazol-7-yl)-3-chlorofuro[2,3-c]pyridin-4-yl]-1h-pyrazol-1-yl}cyclohexan-1-ol bound to tak1-tab1 |
|
209
|
657
|
4jlcA |
Crystal structure of mouse tbk1 bound to su6668 |
|
76
|
275
|
4kspA |
Crystal structure of human b-raf bound to a dfg-out inhibitor tak-632 |
|
80
|
281
|
4knbA |
C-met in complex with osi ligand |
|
91
|
291
|
4lg4A |
Structural basis for autoactivation of human mst2 kinase and its regulation by rassf5 |
|
106
|
348
|
4kinA |
Crystal structure of mitogen-activated protein kinase 14 (p38-h5) complex with 5-(2-chlorophenyl)-n-(5-(cyclopropylcarbamoyl)-2-methylphenyl)-2-thiophenecarboxamide |
|
163
|
504
|
4l9iA |
Bovine g protein coupled receptor kinase 1 in complex with paroxetine |
|
81
|
272
|
4kaoA |
Focal adhesion kinase catalytic domain in complex with 1-(5-tert-butyl-2-p-tolyl-2h-pyrazol-3-yl)-3-(4-pyridin-3- yl-phenyl)-urea |
|
84
|
308
|
4l3pA |
Crystal structure of 2-(1-benzothiophen-7-yl)-4-[1-(piperidin-4-yl)-1h-pyrazol-4-yl]furo[2,3-c]pyridin-7-amine bound to tak1-tab1 |
|
79
|
273
|
4k1bA |
Structure of pim-1 kinase bound to n-(5-(2-fluorophenyl)-1h-pyrrolo[2,3-b]pyridin-3-yl)-5-((((3r,4r)-3-fluoropiperidin-4-yl)methyl)amino)pyrazolo[1,5-a]pyrimidine-3-carboxamide |
|
74
|
275
|
4ksqA |
Crystal structure of human b-raf bound to a dfg-out inhibitor 5b |
|
95
|
257
|
4ldtA |
The structure of h/ceotub1-ubiquitin aldehyde-ubch5b~ub |
|
102
|
351
|
4ka3A |
Structure of map kinase in complex with a docking peptide |
|
91
|
307
|
4l52A |
Crystal structure of 1-(4-{4-[7-amino-2-(1,2,3-benzothiadiazol-7-yl)furo[2,3-c]pyridin-4-yl]-1h-pyrazol-1-yl}piperidin-1-yl)ethan-1-one bound to tak1-tab1 |
|
83
|
337
|
4l45A |
Crystal structures of human p70s6k1-t389e |
|
200
|
657
|
4jl9A |
Crystal structure of mouse tbk1 bound to bx795 |
|
96
|
287
|
4ks7A |
Pak6 kinase domain in complex with pf-3758309 |
|
91
|
287
|
4ks8A |
Pak6 kinase domain in complex with sunitinib |
|
110
|
349
|
4kiqA |
Crystal structure of mitogen-activated protein kinase 14 (p38-h5) complex with ethyl 6-((5-(cyclopropylcarbamoyl)-2-methylphenyl)carbamoyl)-1h-indole-1-carboxylate |
|
110
|
391
|
4l6qA |
Rock2 in complex with benzoxaborole |
|
162
|
613
|
4k2rA |
Structural basis for activation of zap-70 by phosphorylation of the sh2-kinase linker |
|
70
|
263
|
4kujA |
Structural and functional characterization of a novel alpha kinase from entamoeba histolytica |
|
94
|
336
|
4ijpA |
Crystal structure of human prpf4b kinase domain in complex with 4-{5-[(2-chloro-pyridin-4-ylmethyl)-carbamoyl]-thiophen-2-yl}-benzo[b]thiophene-2-carboxylic acid amine |
